Agnete Brunsvik Fredriksen

Founder at NYKODE THERAPEUTICS

Net worth: 24 483 $ as of 2026-08-30

49 year

74 connections

Health Technology

Consumer Services

Finance

Profile

Agnete Brunsvik Fredriksen is the founder of Nykode Therapeutics ASA, established in 2006, serving as Chief Scientific Officer since 2024.
Current jobs include Independent Non-Executive Director at Molecular Partners AG since 2021 and Director at Viginti AS.
Former jobs include Director-Life Science at the University of Oslo, Researcher at Medinnova AS, and Researcher at Affitech A. Education history includes graduate and doctorate degrees from the University of Oslo, with the doctorate conferred in 2007.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
MOLECULAR PARTNERS AG 0.01%	2025-12-30	5,541 ( 0.01% )	24 483 $	2026-08-30

Agnete Brunsvik Fredriksen active positions

Companies	Position	Start
NYKODE THERAPEUTICS	Founder	2006-11-21
MOLECULAR PARTNERS AG	Director/Board Member	2021-04-20
Viginti AS	Director/Board Member	-

All active positions of Agnete Brunsvik Fredriksen

Former positions of Agnete Brunsvik Fredriksen

Companies	Position	End
Affitech A/S Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics	Corporate Officer/Principal	-
University of Oslo University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University	Director/Board Member	-
Medinnova AS Medinnova AS Investment ManagersFinance Medinnova's investment strategy focuses on developing commercial projects in the areas of biomedicine and health care. They work closely with entrepreneurs and public health care employers to develop ideas, evaluate viability of novel inventions, secure intellectual rights for a patent or protection, assist with product development, prepare business plans, and support applications for public funding. The firm is an active investment partner for the establishment of new firms. They provide access to their network of industry expertise, work cohesively with the public policy system, and negotiate with investors and licensees in addition to following-up with licensees.	Corporate Officer/Principal	-

See the detail of Agnete Brunsvik Fredriksen's experience

Training of Agnete Brunsvik Fredriksen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Agnete Brunsvik Fredriksen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
University of Oslo University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Molecular Partners AG Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products	Health Technology
Medinnova AS Medinnova AS Investment ManagersFinance Medinnova's investment strategy focuses on developing commercial projects in the areas of biomedicine and health care. They work closely with entrepreneurs and public health care employers to develop ideas, evaluate viability of novel inventions, secure intellectual rights for a patent or protection, assist with product development, prepare business plans, and support applications for public funding. The firm is an active investment partner for the establishment of new firms. They provide access to their network of industry expertise, work cohesively with the public policy system, and negotiate with investors and licensees in addition to following-up with licensees.	Finance
Nykode Therapeutics ASA Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer	Health Technology
Affitech A/S Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics	Health Technology
Viginti AS